| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.007 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.02 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.28 | 0.08 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.28 | 0.1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.25 | 0.2 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.25 | 6e-10 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-11 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.02 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-11 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-11 |